Search research articles
Contact Us
Filters
Showing results (81-90 of 133) with videos related to
Page
of 14
Sort By:
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|
January 1, 1992
[The EBNA2 coding region in the viral genome of Epstein-Barr virus (EBV)-positive cases of Hodgkin's disease]
B Borisch, A Telenti, I Hennig, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 22, 2002
Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction: application for the assessment of their transplacental passage at delivery
C Marzolini, A Béguin, A Telenti, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 19, 2005
Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry
S Colombo, A Beguin, A Telenti, et al.
Genes and Immunity
|
June 6, 2008
The evolutionary history of the CD209 (DC-SIGN) family in humans and non-human primates
M Ortiz, H Kaessmann, K Zhang, et al.
Tissue Antigens
|
April 21, 2007
Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection
A Rauch, R Laird, E McKinnon, et al.
AIDS (London, England)
|
January 6, 1999
Changes in renal function associated with indinavir
K Boubaker, P Sudre, F Bally, et al.
Hepatology (Baltimore, Md.)
|
August 1, 1991
Epstein-Barr virus and persistent graft dysfunction after liver transplantation
A Telenti, T F Smith, J Ludwig, et al.
Revue Medicale Suisse
|
September 27, 2013
[An update on hepatitis E]
P Hiroz, J Gouttenoire, V L Dao Thi, et al.
The Journal of Investigative Dermatology
|
November 26, 1999
HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases
M Borg-von Zepelin, I Meyer, R Thomssen, et al.
AIDS (London, England)
|
September 14, 2000
Virological and immunological characteristics of HIV treatment failure
D Kaufmann, M Muñoz, G Bleiber, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 133) with videos related to
Sort By:
Page
of 14
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|
January 1, 1992
[The EBNA2 coding region in the viral genome of Epstein-Barr virus (EBV)-positive cases of Hodgkin's disease]
B Borisch, A Telenti, I Hennig, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 22, 2002
Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction: application for the assessment of their transplacental passage at delivery
C Marzolini, A Béguin, A Telenti, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 19, 2005
Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry
S Colombo, A Beguin, A Telenti, et al.
Genes and Immunity
|
June 6, 2008
The evolutionary history of the CD209 (DC-SIGN) family in humans and non-human primates
M Ortiz, H Kaessmann, K Zhang, et al.
Tissue Antigens
|
April 21, 2007
Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection
A Rauch, R Laird, E McKinnon, et al.
AIDS (London, England)
|
January 6, 1999
Changes in renal function associated with indinavir
K Boubaker, P Sudre, F Bally, et al.
Hepatology (Baltimore, Md.)
|
August 1, 1991
Epstein-Barr virus and persistent graft dysfunction after liver transplantation
A Telenti, T F Smith, J Ludwig, et al.
Revue Medicale Suisse
|
September 27, 2013
[An update on hepatitis E]
P Hiroz, J Gouttenoire, V L Dao Thi, et al.
The Journal of Investigative Dermatology
|
November 26, 1999
HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases
M Borg-von Zepelin, I Meyer, R Thomssen, et al.
AIDS (London, England)
|
September 14, 2000
Virological and immunological characteristics of HIV treatment failure
D Kaufmann, M Muñoz, G Bleiber, et al.
Page
of 14